[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336845-105":59,"doc-detail-336845-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","causal-association-between-metabolites-and-upper-gastrointestinal-tumors-a-mendelian-randomization-study","Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study","","Upper gastrointestinal tumors, especially gastric cancer and esophageal cancer, remain major causes of morbidity and mortality worldwide, yet few metabolites are established as reliable biomarkers. A comprehensive two-sample Mendelian randomization analysis assessed causal relationships between 1,400 metabolites and UGI cancer using inverse variance weighting and weighted medians, supported by sensitivity tests for heterogeneity and pleiotropy. Functional experiments further validated the findings. The study identified 57 metabolites linked to esophageal cancer and 58 linked to gastric cancer, highlighting fructosyllysine and the 2'-deoxyuridine to cytidine ratio as risk factors and the C3 ratio as a protective factor.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/causal-association-between-metabolites-and-upper-gastrointestinal-tumors-a-mendelian-randomization-study/336845/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/causal-association-between-metabolites-and-upper-gastrointestinal-tumors-a-mendelian-randomization-study/336845.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What method was used to test causality between metabolites and upper gastrointestinal tumors?","Question",{"text":112,"@type":113},"A comprehensive two-sample Mendelian randomization analysis was performed using publicly available genetic data, with inverse variance weighting and weighted medians, plus sensitivity analyses for heterogeneity and pleiotropy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which metabolites were identified as risk factors for both esophageal cancer and gastric cancer?",{"text":117,"@type":113},"Fructosyllysine and the 2'-deoxyuridine to cytidine ratio were reported as risk factors for both esophageal cancer and gastric cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What role did the carnitine to protonylcarnitine (C3) ratio play in the study?",{"text":121,"@type":113},"The C3 ratio served as a protective factor, and functional experiments showed carnitine inhibited proliferation of EC and GC cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336845,1790832121,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","MOLECULAR MEDICINE REPORTS 30: 212, 2024  \nCausal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study  \nPENGKHUN NOV 1* , CHONGYANG ZHENG 1* , DUANYU WANG 1 , SYPHANNASOU2 , SOCHEAT TOUCH2 , SAMNANG KOUY2 , PEIZAN NI 1 , QIANZI KOU 1 , YING LI 1 , ARZOO PRASAI 1 , WEN FU 1 , KUNPENG DU 1 and JIQIANG LI 1  \n1  \nDepartment of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510282, P.R. China; 2Department of Radiation Oncology and Oncology, Khmer‑Soviet Friendship Hospital of University of Health Sciences, Phnom Penh 120110, Cambodia  \nReceived July 1, 2024; Accepted September 3, 2024  \nDOI: 10. 3892/mmr.2024.13336  \nAbstract. Upper gastrointestinal (UGI) tumors, notably gastric cancer (GC) and esophageal cancer (EC), are significant global health concerns due to their high morbidity and mortality rates. However, only a limited number of metabolites have been identified as biomarkers for these cancers. To explore the asso‑ ciation between metabolites and UGI tumors, the present study conducted a comprehensive two‑sample Mendelian randomiza‑ tion (MR) analysis using publicly available genetic data. In the present study, the causal relationships were examined between 1,400 metabolites and UGI cancer using methods such as inverse variance weighting and weighted medians, along with sensitivity analyses for heterogeneity and pleiotropy. Functional experiments were conducted to validate the MR results. The analysis identified 57 metabolites associated with EC and 58 with GC. Key metabolites included fructosyllysine [EC: Odds ratio (OR)=1 .450, 95% confidence interval (CI)=1 .087‑1.934, P=0 . 011; GC: OR=1 .728, 95% CI=1 .202‑2 . 483, P=0 . 003], 2'‑deoxyuridine to cytidine ratio (EC: OR=1.464, 95% CI=1.111‑1.929, P=0 .007; GC: OR=1.464, 95% CI=1.094‑1.957, P=0.010) and carnitine to protonylcarnitine (C3) ratio (EC: OR=0 . 655, 95% CI=0 .499‑0. 861, P=0 .002; GC: OR=0 . 664, 95% CI=0.486‑0.906, P=0.010) . Notably, fructosyllysine levels and the 2'‑deoxyuridine to cytidine ratio were identified as risk factors for both EC and GC, while the C3 ratio served as a protective factor. Functional experiments demonstrated  \nCorrespondence to: Professor Jiqiang Li or Dr Kunpeng Du, Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, 253 Mid Gongye Avenue, Haizhu, Guangzhou, Guangdong 510282, P.R. China  \nE‑mail: [ljq821028@126.com](ljq821028@126.com)  \nE‑mail: [dkp321098@smu.edu.cn](dkp321098@smu.edu.cn)  \n*Contributed equally  \nKey words: esophageal cancer, gastric cancer, metabolites, Mendelian randomization, UK Biobank  \nthat fructosyllysine and the 2'‑deoxyuridine to cytidine ratio promoted the proliferation of EC and GC cells, whereas carnitine inhibited their proliferation. In conclusion, the present findings provide insights into the causal factors and biomarkers associ‑ ated with UGI tumors, which may be instrumental in guiding targeted dietary and pharmacological interventions, thereby contributing to the prevention and treatment of UGI cancer.  \nIntroduction  \nUpper gastrointestinal (UGI) tumors, characterized by high morbidity and mortality rates, present significant global health challenges, especially esophageal cancer (EC; 510,716 new cases in 2022) and gastric cancer (GC; ~1 million new cases in 2022) (1). The prognosis for patients with UGI cancer remains poor in multiple countries, primarily because of insufficient screening initiatives (2,3) . Elucidating the mechanisms that initiate and advance UGI cancers is essential to develop successful prevention and therapeutic approaches. Growing evidence shows that metabolites, small molecules intermedi‑ ately produced during multiple cellular metabolic reactions, are implicated in the pathways leading to UGI tumors . Progress in molecular biology and the introduction of diverse omics techniques have markedly advanced epidemiological","cbCaiuC0yW2I9l6m","https://ap.wps.com/l/cbCaiuC0yW2I9l6m","pdf",14223921,18,"English","# Abstract\n# Introduction","[{\"question\":\"What method was used to test causality between metabolites and upper gastrointestinal tumors?\",\"answer\":\"A comprehensive two-sample Mendelian randomization analysis was performed using publicly available genetic data, with inverse variance weighting and weighted medians, plus sensitivity analyses for heterogeneity and pleiotropy.\"},{\"question\":\"Which metabolites were identified as risk factors for both esophageal cancer and gastric cancer?\",\"answer\":\"Fructosyllysine and the 2'-deoxyuridine to cytidine ratio were reported as risk factors for both esophageal cancer and gastric cancer.\"},{\"question\":\"What role did the carnitine to protonylcarnitine (C3) ratio play in the study?\",\"answer\":\"The C3 ratio served as a protective factor, and functional experiments showed carnitine inhibited proliferation of EC and GC cells.\"}]","Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study | PDF",1790016842,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97b99154a8374cfcf13ba3c93bd445a9.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee002801198e02b0faf5eee696cf7fe5.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/628e652cf3216f741b8b02fa9ce51456.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/278f5c54beba06fca33be2e60704defc.webp",980,1353]